• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

AXA Framlington Biotech Z INC

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderAXA Investment Managers UK Ltd
Fund SummaryThe aim of this Fund is to provide long-term capital growth.
Fund codeFMBZI
ManagersLinden Thomson, Dani Saurymper
Manager Tenure8 years
Morningstar CategorySector Equity Biotechnology
IMA SectorSpecialist
Fund Size£463 million
Fund TypeOEIC
Management StyleActive
Ongoing Charge Figure (OCF)0.82%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£1.5090
Buy Price£1.5090
Price Change-0.6583%
Price Date25th September 2020
YieldCurrently unavailable
Dividend FrequencySemi-Annually
ISA EligibleYes
SIPP EligibleYes
Inception Date2nd March 2015
Fund StatusOPEN

3-year Mean Monthly Return: 0.846%

Annual Returns2019201820172016201520142013201220112010
Fund Performance+33.28%+1.02%+7.80%+27.22%-21.97%+55.28%+32.55%+39.88%+21.92%+23.29%
Benchmark Performance
(Sector Equity Biotechnology)
Time PeriodCumulativeBenchmark Performance
(Sector Equity Biotechnology)
Fund Compared to Benchmark
1 day-0.66%+16.08%-16.73%
1 week-1.18%+3.23%-4.41%
1 month3.78%-5.90%+9.68%
3 months-4.43%+22.35%-26.78%
6 months25.65%+28.74%-3.09%
1 year36.68%+9.15%+27.53%
3 years9.99%+9.02%+0.97%
5 years7.96%+17.33%-9.37%
10 years18.95%+8.23%+10.72%
Since inception9.00%Currently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
Regeneron Pharmaceuticals IncUSA7.71%
Amgen IncUSA7.33%
Biogen IncUSA5.74%
Vertex Pharmaceuticals IncUSA4.53%
Alexion Pharmaceuticals IncUSA4.45%
Gilead Sciences IncUSA4.27%
Seattle Genetics IncUSA4.15%
Incyte CorpUSA3.32%
Biomarin Pharmaceutical IncUSA3.25%
Illumina IncUSA3.10%

Currently unavailable